Quick search Find article
Quick search
Find article

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

Rameshwer Shukla, Thommey P Thomas, Ankur M Desai, Alina Kotlyar, Steve J Park and James R Baker Jr

Show affiliations


Herceptin, a humanized monoclonal antibody that binds to human growth factor receptor-2 (HER2), was covalently attached to a fifth-generation (G5) polyamidoamine dendrimer containing the cytotoxic drug methotrexate. The specific binding and internalization of this conjugate labeled with FITC was clearly demonstrated in cell lines overexpressing HER2 by flow cytometry as well as confocal microscopic analysis. In addition, binding and uptake of antibody conjugated dendrimers was completely blocked by excess non-conjugated herceptin. The dendrimer conjugate was also shown to inhibit the dihydrofolate reductase with similar activity to methotrexate. Co-localization experiments with lysotracker red indicate that antibody conjugate, although internalized efficiently into cells, has an unusually long residence time in the lysosome. Somewhat lower cytotoxicity of the conjugate in comparison to free methotrexate was attributed to the slow release of methotrexate from the conjugate and its long retention in the lysosomal pocket.


PACS

47.63.mh Transport processes and drug delivery

87.15.N- Properties of solutions of macromolecules

87.14.E- Proteins

87.15.M- Spectra of biomolecules

87.64.mk Confocal

Subjects

Fluid dynamics

Medical physics

Biological physics

Dates

Issue 29 (23 July 2008)

Received 3 April 2008, in final form 9 May 2008

Published 10 June 2008



View by subject




Export








Please login to access our web services, or create an account if you don't yet have one.

You must have cookies enabled in your web browser to be able to login.

Username
Password

Forgotten your password? Get a new one here.